Genaera Corporation

Organization

Plymouth Meeting, PA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Interleukin-9 receptor mutants
- Patent number 7,704,710
- Issue date Apr 27, 2010
- Genaera Corporation
- Roy Clifford Levitt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Interleukin-9 mutein peptides
- Patent number 7,700,088
- Issue date Apr 20, 2010
- Genaera Corporation
- Roy Clifford Levitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mucin synthesis inhibitors
- Patent number 7,504,409
- Issue date Mar 17, 2009
- Genaera Corporation
- Yuhong Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic uses for aminosterol compounds
- Patent number 7,410,959
- Issue date Aug 12, 2008
- Genaera Corporation
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid encoding an interleukin-9 receptor variant
- Patent number 7,384,767
- Issue date Jun 10, 2008
- Genaera Corporation
- Roy Clifford Levitt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mucin synthesis inhibitors
- Patent number 7,345,051
- Issue date Mar 18, 2008
- Genaera Corporation
- Yuhong Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating ICACC protein associated diseases
- Patent number 7,211,254
- Issue date May 1, 2007
- Genaera Corporation
- Kenneth J. Holroyd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid encoding an interleukin-9 receptor variant
- Patent number 7,208,292
- Issue date Apr 24, 2007
- Genaera Corporation
- Roy Clifford Levitt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Interleukin-9 mutein peptides
- Patent number 7,192,578
- Issue date Mar 20, 2007
- Genaera Corporation
- Roy Clifford Levitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Asthma associated factors as targets for treating atopic allergies...
- Patent number 7,074,778
- Issue date Jul 11, 2006
- Genaera Corporation
- Roy C. Levitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding interleukin-9 receptor variants
- Patent number 7,056,698
- Issue date Jun 6, 2006
- Genaera Corporation
- Roy Clifford Levitt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of neovascularization disorders with squalimine
- Patent number 6,962,909
- Issue date Nov 8, 2005
- Genaera Corporation
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Regioselective and stereoselective oxidation of fused ring systems...
- Patent number 6,933,383
- Issue date Aug 23, 2005
- Genaera Corporation
- William A. Kinney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mucin synthesis inhibitors
- Patent number 6,737,427
- Issue date May 18, 2004
- Genaera Corporation
- Yuhong Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding a chloride channel protein
- Patent number 6,716,603
- Issue date Apr 6, 2004
- Genaera Corporation
- Kenneth J. Holroyd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating asthma with interleukin-9 receptor antibodies
- Patent number 6,645,492
- Issue date Nov 11, 2003
- Genaera Corporation
- Roy Clifford Levitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating asthma using soluble IL-9 receptor variants
- Patent number 6,602,850
- Issue date Aug 5, 2003
- Genaera Corporation
- Roy Clifford Levitt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of carcinomas using squalamine in combination with other...
- Patent number 6,596,712
- Issue date Jul 22, 2003
- Genaera Corporation
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for identification of agents which modulate chloride channe...
- Patent number 6,576,434
- Issue date Jun 10, 2003
- Genaera Corporation
- Kenneth J. Holroyd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aminosterol compounds and uses thereof
- Patent number 6,388,108
- Issue date May 14, 2002
- Genaera Corporation
- Meena Rao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating asthma with interleukin-9 antibodies
- Patent number 6,261,559
- Issue date Jul 17, 2001
- Genaera Corporation
- Roy Clifford Levitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Antibodies against inducible TH2 cell factors
- Publication number 20080096981
- Publication date Apr 24, 2008
- Genaera Corporation
- Charles Qu Dong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid encoding an interleukin-9 receptor variant
- Publication number 20070190609
- Publication date Aug 16, 2007
- Genaera Corporation
- Roy Clifford Levitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Asthma associated factors as targets for treating atopic allergies...
- Publication number 20070088003
- Publication date Apr 19, 2007
- Genaera Corporation
- Roy C. Levitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aminosterol compounds useful as inhibitors of the sodium/proton exc...
- Publication number 20060183928
- Publication date Aug 17, 2006
- Genaera Corporation
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of neovascularization disorders with squalamine
- Publication number 20060166950
- Publication date Jul 27, 2006
- Genaera Corporation
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Regioselective and stereoselective oxidation of fused ring systems...
- Publication number 20050187202
- Publication date Aug 25, 2005
- Genaera Corporation
- William A. Kinney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Mucin synthesis inhibitors
- Publication number 20040254096
- Publication date Dec 16, 2004
- Genaera Corporation
- Yuhong Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUCIN SYNTHESIS INHIBITORS
- Publication number 20030236220
- Publication date Dec 25, 2003
- Genaera Corporation
- Yuhong Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aminosterol compounds useful as inhibitors of the sodium/proton exc...
- Publication number 20030149287
- Publication date Aug 7, 2003
- Genaera Corporation
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
78553725 - REVISA
- Serial number 78553725
- Filing date Jan 25, 2005
- Genaera Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78517923 - EVIZON
- Serial number 78517923
- Filing date Nov 16, 2004
- Genaera Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78517920 - REVIDAL
- Serial number 78517920
- Filing date Nov 16, 2004
- Genaera Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78517132 - LOMUCIN
- Serial number 78517132
- Filing date Nov 15, 2004
- Genaera Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78517130
- Serial number 78517130
- Filing date Nov 15, 2004
- Genaera Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76223015
- Serial number 76223015
- Filing date Mar 12, 2001
- Genaera Corporation
- 5 - Pharmaceutical and veterinary preparations

Genaera Corporation

Organization

Patents Grantslast 30 patents

Interleukin-9 receptor mutants

Interleukin-9 mutein peptides

Mucin synthesis inhibitors

Therapeutic uses for aminosterol compounds

Nucleic acid encoding an interleukin-9 receptor variant

Mucin synthesis inhibitors

Methods for treating ICACC protein associated diseases

Nucleic acid encoding an interleukin-9 receptor variant

Interleukin-9 mutein peptides

Asthma associated factors as targets for treating atopic allergies...

Nucleic acids encoding interleukin-9 receptor variants

Treatment of neovascularization disorders with squalimine

Regioselective and stereoselective oxidation of fused ring systems...

Mucin synthesis inhibitors

Nucleic acids encoding a chloride channel protein

Methods of treating asthma with interleukin-9 receptor antibodies

Method of treating asthma using soluble IL-9 receptor variants

Treatment of carcinomas using squalamine in combination with other...

Methods for identification of agents which modulate chloride channe...

Aminosterol compounds and uses thereof

Methods of treating asthma with interleukin-9 antibodies

Patents Applicationslast 30 patents

Antibodies against inducible TH2 cell factors

Nucleic acid encoding an interleukin-9 receptor variant

Asthma associated factors as targets for treating atopic allergies...

Aminosterol compounds useful as inhibitors of the sodium/proton exc...

Treatment of neovascularization disorders with squalamine

Regioselective and stereoselective oxidation of fused ring systems...

Mucin synthesis inhibitors

MUCIN SYNTHESIS INHIBITORS

Aminosterol compounds useful as inhibitors of the sodium/proton exc...

Trademarklast 30 trademarks

78553725 - REVISA

78517923 - EVIZON

78517920 - REVIDAL

78517132 - LOMUCIN

78517130

76223015